SYNTHESE VON NOROXYMORPHON
Patent europeic · EP3720862 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP3720862
- Numer da la dumonda
- EP18814822
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 29-11-2018
- Publitgà
- 14-10-2020
- Concedì
- 27-10-2021
- La protecziun finescha il pli tard
- 28-11-2038
- Proxima taxa annuala scadenta
- 30-11-2026
- Classas IPC
- C07D 498/08 (2006.01)A61P 25/04 (2006.01)A61K 31/485 (2006.01)
- Prioritad
- EP 17205507 05.12.2017
- Dumonda PCT
- PCT/EP2018/082986 29.11.2018
- Publicaziun PCT
- WO2019/110413 13.06.2019
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-12-2025
Midada
Published in Swissreg on 01.12.2025
- 01-12-2024
Midada
Published in Swissreg on 01.12.2024
- 01-12-2023
Midada
Published in Swissreg on 01.12.2023
- 31-01-2023
Midada
Published in Swissreg on 31.01.2023
- 07-09-2022
Midada
Published in Swissreg on 07.09.2022
- 25-11-2021
Represchentant inscrit
- Representative
- TR-IP Consulting LLC, Route de Coutset 18, 1485 Nuvilly
Published in Swissreg on 25.11.2021
- 27-10-2021
Concedì
Published in Swissreg on 27.10.2021
Partidas
Represchentant
Inventur
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.